Unicycive TherapeuticsUNCY
那斯達克 · USD
4.64
+0.09
(+1.98%)
盤中 10/01 02:06 (UTC+8)
10/01 02:06 (UTC+8)
Unicycive TherapeuticsUNCY
4.64
+0.09
(+1.98%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 10,141 | 8,437 | 7,224 | 7,326 | 6,978 | 7,989 | 9,261 | 6,250 | 7,402 | - |
研發費用 | 2,789 | 1,607 | 2,250 | 2,935 | 1,765 | 2,171 | 5,288 | 3,045 | 4,868 | 6,813 |
推銷及管理費用 | 7,352 | 6,830 | 4,974 | 4,391 | 5,213 | 5,818 | 3,973 | 3,205 | 2,534 | 2,391 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -10,141 | -8,437 | -7,224 | -7,326 | -6,978 | -7,989 | -9,261 | -6,250 | -7,402 | -9,204 |
其他收入及費用 | 8,419 | -4,386 | -7,417 | 1,347 | 529 | 8,574 | -12,244 | 2,169 | 17,273 | -11,739 |
利息費用 | - | - | 27 | 31 | -2 | 15 | 20 | 15 | 16 | 20 |
稅前純益 | -1,722 | -12,823 | -14,668 | -6,010 | -6,447 | 570 | -21,525 | -4,096 | 9,855 | -20,963 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -1,722 | -12,823 | -14,668 | -6,010 | -6,447 | 570 | -21,525 | -4,096 | 9,855 | -20,963 |
基本每股稅後盈餘(元) | -0.06 | -0.54 | -0.82 | -0.33 | -0.52 | - | 0.02 | -0.05 | 0.08 | -0.61 |
稀釋每股稅後盈餘(元) | -0.03 | -0.54 | -0.82 | -0.36 | 0.01 | -0.05 | -0.26 | 0.03 | 0.27 | -0.61 |
基本平均股數(千股) | 26917.00 | 23908.00 | - | 18065.00 | 12302.00 | 116818.00 | 106171.00 | 88943.00 | 37914.00 | 34912.00 |
稀釋平均股數(千股) | 26917.00 | 23908.00 | - | 18065.00 | 12302.00 | 123834.00 | 50033.00 | 88943.00 | 94052.00 | 34912.00 |
還原基本每股稅後盈餘(元) | -0.06 | -0.54 | -0.82 | -0.33 | -0.52 | - | 0.20 | -0.46 | 0.80 | -6.10 |
還原稀釋每股稅後盈餘(元) | -0.03 | -0.54 | -0.82 | -0.36 | 0.01 | -0.50 | -2.64 | 0.34 | 2.70 | -6.10 |
還原基本平均股數(千股) | 26,917 | 23,908 | - | 18,065 | 12,302 | 11,681 | 10,617 | 8,894 | 3,791 | 3,491 |
還原稀釋平均股數(千股) | 26,917 | 23,908 | - | 18,065 | 12,302 | 12,383 | 5,003 | 8,894 | 9,405 | 3,491 |
EBITDA(千元) | -1,604 | -12,600 | -14,490 | -5,831 | -6,311 | 720 | -21,371 | -3,958 | 9,758 | -20,659 |